Mayne IK, Tyzack-Clark HM, McGovern AP. Studies are needed to support optimal insulin dose titration in gestational diabetes mellitus: A systematic review.
Diabetes Metab Syndr 2023;
17:102746. [PMID:
36966543 DOI:
10.1016/j.dsx.2023.102746]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/25/2022] [Revised: 03/11/2023] [Accepted: 03/14/2023] [Indexed: 03/28/2023]
Abstract
BACKGROUND AND AIMS
We aimed to summarise the existing literature on insulin dose titration in gestation diabetes.
METHODS
Databases: Medline, EMBASE, CENTRAL and CINAHL were systematically searched for trials and observational studies comparing insulin titration strategies in gestational diabetes.
RESULTS
No trials comparing insulin dose titration strategies were identified. Only one small (n = 111) observational study was included. In this study, patient-led daily basal insulin titration was associated with higher insulin doses, tighter glycaemic control, and lower birthweight, vs weekly clinician-led titration.
CONCLUSIONS
There is a paucity of evidence to support optimal insulin titration in gestational diabetes. Randomized trials are required.
Collapse